S

    STSS (STSS)

    Official site

    MEDICAL INSTRUMENTS & SUPPLIES

    $1.42
    -0.05 (-3.40%)

    Last updated: Aug 28, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    18%(2/11)
    Avg Surprise
    -433439.03%
    PeriodReportedEst.SurpriseB/MYoY
    Mar 26
    		$-1.19N/AN/ABeat+99.8%
    Sep 25
    		$-4.33$-1.01-328.71%Miss+98.9%
    Jun 25
    		$3.58$-0.94+480.85%Beat+100.6%
    Mar 25
    		$38.62N/AN/ABeat+77340.0%
    Dec 24
    		$-662.99$-0.03-2209872.33%Miss-389895.1%
    Sep 24
    		$-379.55$-0.04-948782.25%Miss-223166.4%
    Jun 24
    		$-643.64$-0.04-1609005.50%Miss-292464.6%
    Mar 24
    		$-0.05$-0.04-25.00%Miss+61.5%
    Dec 23
    		$-0.17$-0.14-21.43%Miss-70.0%
    Sep 23
    		$-0.17$-0.09-88.89%Miss+34.6%
    Jun 23
    		$-0.22$-0.08-175.00%Miss-466.7%
    Mar 23
    		$-0.13$-0.13+0.00%Beat+23.5%
    Dec 22
    		$-0.10$-0.09-11.11%Miss+33.3%
    Sep 22
    		$-0.26$0.00N/AMiss-188.9%
    Jun 22
    		$0.06$0.00N/ABeat-
    Mar 22
    		$-0.17$0.00N/AMiss-
    Dec 21
    		$-0.15$0.00N/AMiss-
    Sep 21
    		$-0.09$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio0.04EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage-919.43x
    Current Ratio8.28xQuick Ratio8.08x
    Trading Statistics
    BetaN/AAvg Volume402.21K
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.27
    SMA 20$1.22
    SMA 50$1.21
    SMA 200$1.55
    EMA 10$1.31
    EMA 20$1.26
    EMA 50$1.27
    EMA 200$3.70

    MACD

    Line: 0.03Signal: 0.00Hist: 0.03

    ADX

    ADX: 24.4+DI: 26.4-DI: 10.9

    Aroon & PSAR

    Aroon Up96.0
    Aroon Down64.0
    PSAR$1.11

    Bollinger Bands

    Upper Band$1.51
    Lower Band$0.94
    %B Position4658%(Upper)
    Band Width0.85

    RSI (14-Day)

    Neutral
    59.8

    Momentum Oscillators

    Stoch %K74.4
    Stoch %D72.9
    Williams %R-23.6
    ROC (10d)44.9%
    Momentum0.44
    CCI (20d)109.0
    MFI (14d)68.0

    Volatility Measures

    ATR (14d)$0.15(10.6%)
    StdDev (20d)0.14
    Hist Vol136.5%(High)

    Volume Flow

    VWAP$1.40
    OBV2.9B
    AD Line9923.4B
    CMF (20d)0.038

    Volume Metrics

    Avg Vol (20d)434.6K
    Vol Ratio0.5x(Low)
    VWMA (20d)$1.27

    Pivot Points

    R3$1.79
    R2$1.68
    R1$1.57
    Pivot Point$1.46
    S1$1.35
    S2$1.24
    S3$1.13

    Advanced Oscillators

    TSI8.09
    Ultimate Osc52.6
    KST2.99

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$192,780$-102,224$83,622$222,722$0$-8,226$0$0$8,226$-8,226$0$0
    Cost of Revenue$202,578$-1,890,582$1.25M$1.25M$130,921$190,898$194,486$193,109$195,411$234,116$203,952$237,091
    Gross Profit$-9,798$1.79M$-1,169,656$-1,032,027$-130,921$-190,898$-194,486$-193,109$-195,411$-234,116$-203,952$-237,091
    Operating Expenses$4.56M$-100,593,671$109.48M$1.97M$2.02M$1.89M$1.82M$1.73M$1.65M$2.68M$2.15M$2.30M
    R&D$137,097$-31,279$152,109$61,455$82,016$6,653$145,611$180,297$7,318$592,681$23,905$224,260
    SG&A$7.55M$-95,086,407$110.72M$1.91M$1.94M$1.56M$1.87M$1.74M$1.98M$2,095$2.13M$2.31M
    Operating Income$-4,566,106$102.38M$-110,646,359$-3,006,382$-2,021,769$-2,076,347$-2,015,209$-1,921,100$-1,844,052$-2,918,156$-2,358,358$-2,532,335
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$10,038$120,551$68,488$96,953$626,991$2.48M$0$181,227$36,792$286,389$17,620$40,079
    Income Before Tax$-86,239,232$-170,490,283$-105,333,293$3.56M$1.93M$-4,556,428$-1,685,060$-2,102,327$-982,386$-3,131,639$-2,022,344$-2,605,825
    Income Tax Expense$0$12.17M$0$0$-29,999$-30,000$-1,685,060$1$-1$-30,000$-336,014$73,490
    Net Income$-86,239,232$-182,656,973$-105,333,293$3.56M$1.93M$-4,526,428$-1,685,060$-2,102,327$-982,386$-3,101,639$-2,022,344$-2,605,825
    EBITDA$-4,543,772$-154,244,267$-110,500,724$-2,865,975$-1,890,848$-4,365,530$-1,490,578$-1,909,213$-786,971$-2,897,519$-1,818,395$-2,368,733
    EBIT$-4,566,106$-153,959,844$-110,646,359$-3,006,382$-2,021,769$-4,556,428$-1,685,064$-2,102,322$-982,382$-3,131,635$-2,022,347$-2,605,824
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about STSS

    News

    Prefilled Syringes Market worth $13.14 billion in 2030

    The global prefilled syringes market is projected to grow from USD 7.10 billion in 2024 to USD 13.14 billion in 2030, at a CAGR of 10.8%. This growth is driven by the increasing prevalence of chronic diseases, a growing elderly population, and the rising adoption of biological drugs. Key segments include conventional prefilled syringes by type, glass prefilled syringes by material, single-chamber prefilled syringes by design, and the cancer application segment, with North America holding the largest market share in 2023.

    MarketsandMarkets•7/29/26•
    Somewhat-Bullish

    SKYA SEC Filings - SkyAI, Inc. 10-K, 10-Q, 8-K Forms

    This page provides a comprehensive overview of SkyAI, Inc.'s (SKYA) SEC filings, including 10-K annual reports, 10-Q quarterly earnings, and 8-K material events. It details the company's rebranding from Sharps Technology, Inc., its pivot to an AI- and blockchain-based financial platform for the Global South, and significant financial disclosures related to its digital asset strategy and executive appointments. The filings offer insights into SkyAI's evolving business model, governance practices, and corporate transactions.

    Stock Titan•7/1/26•
    Somewhat-Bullish

    Sharps Technology Inc (STSS) Earnings Forecast: Future EPS & Revenue Growth Estimates

    This article provides an earnings forecast for Sharps Technology Inc (STSS), noting that no earnings forecast score is currently available, which is below the industry average. Analysts have set an average price target of $22.00 for STSS, with both the highest and lowest forecasts also at $22.00. The company has not yet disclosed relevant financial data for an EPS, revenue, or net profit forecast.

    TradingKey•6/19/26•
    Neutral

    Sharps Technology Inc (STSSW) Technical Analysis: Support, Resistance, Indicators & Moving Averages

    This article provides a technical analysis of Sharps Technology Inc (STSSW), focusing on various indicators and moving averages. It reports that based on these technical signals, the current recommendation is to sell. The analysis includes details on MACD, RSI, KDJ, and different moving averages, noting both buy and sell signals from various indicators.

    TradingKey•6/18/26•
    Neutral

    Sharps Technology Inc (STSS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

    This article from TradingKey provides an overview of Sharps Technology Inc (STSS), including its current stock price and market capitalization. It indicates that relevant data for revenue breakdown by business segments and regions has not yet been disclosed by the company. The page also offers general financial information and analytical tools available on the TradingKey platform.

    TradingKey•6/17/26•
    Neutral

    Frequently Asked Questions About STSS

    Does STSS pay dividends?
    STSS (STSS) does not currently pay a regular dividend.
    What is STSS's P/E ratio?
    STSS has a price-to-earnings (P/E) ratio of 0.04.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In